Roee Farber, ZipBio CEO
September 5, 2024 08:00 AM EDT
Financing
Startups
AI

Ex­clu­sive: Zip­Bio launch­es us­ing gen­er­a­tive AI to make com­pact pro­teins

Ryan Cross

Senior Science Correspondent

As sev­er­al well-fund­ed com­pa­nies race to make gen­er­a­tive AI mod­els that can de­sign new pro­tein ther­a­pies from scratch, one small start­up has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times